The TaqMan PCR classifies six types of Trypanosoma cruzi and was validated on a large international set of samples. 

The firm is aiming at in vitro diagnostics, applied markets, and next-generation sequencing sample preparation.

The firm is pursuing CE-IVD clearance of the new platform populated with a menu of its MGB assays.

The companies' first offering is expected to be a multiplex respiratory disease panel.

The test adds to a growing menu of approved assays for the cobas 4800 system.

Methods and compositions for DNA fragmentation and tagging by transposases
Helicase dependent isothermal amplification using nicking enzymes
Mutational analysis
Method for amplifying nucleic acids
Compositions, methods and kits for nucleic acid synthesis and amplification
Determination of KIR haplotypes associated with disease